Emmaus Life Sciences, Inc. (EMMA)
Makes medicines for rare diseases like sickle cell and certain cancers.
$0.01-0.06%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-26.7%
The outlook
EMMA is trading near its 52-week low, roughly one-third of the way up from bottom to top of its annual range. The stock sits mixed relative to its moving averages, and analyst sentiment leans bearish overall. Current data reflects a weak technical setup with limited upside positioning in recent price action.
What’s behind the score
Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Market cap
$772,070
52-wk high
$0.02
52-wk low
$0.01
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
—